• LAST PRICE
    0.8200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.7000/ 4
  • Ask / Lots
    0.8220/ 8
  • Open / Previous Close
    0.8400 / 0.8200
  • Day Range
    Low 0.7900
    High 0.8600
  • 52 Week Range
    Low 0.6538
    High 8.2065
  • Volume
    112,892
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.83
TimeVolumeSQZ
09:32 ET28390.82
09:33 ET11190.8301
09:42 ET2000.835001
09:44 ET11140.83
09:48 ET12000.86
10:09 ET1000.835001
10:13 ET1800.84
10:24 ET4690.83
10:27 ET4000.8301
10:36 ET1000.83
11:00 ET10000.815
11:12 ET20000.8399
11:14 ET10000.84
11:16 ET66000.8505
11:23 ET10000.8436
11:38 ET23410.84
11:56 ET20000.84
12:03 ET17040.815
12:19 ET52440.8399
12:30 ET100000.8399
12:32 ET1000.84
12:46 ET5000.829501
12:48 ET1150.8365
12:57 ET50000.83
01:13 ET19520.8205
01:18 ET17000.83
01:20 ET14000.83
01:22 ET2000.83
01:24 ET7140.83
01:26 ET14240.83
01:36 ET6030.83
01:38 ET13180.83
01:42 ET57000.83
02:09 ET8000.8299
02:12 ET10550.8101
02:18 ET2550.82
02:21 ET7200.82
02:56 ET30000.82
02:59 ET102250.81
03:01 ET63280.795
03:03 ET9550.8044
03:06 ET12090.8
03:08 ET13790.804699
03:10 ET1000.795
03:12 ET27990.79
03:17 ET2000.8
03:19 ET1500.796
03:21 ET4000.79735
03:26 ET4050.8047
03:32 ET1800.804699
03:33 ET3000.8001
03:35 ET1130.8036
03:37 ET11490.8099
03:39 ET7800.8
03:42 ET5350.81
03:44 ET5000.805
03:46 ET5900.8077
03:48 ET4420.79
03:50 ET2800.79
03:51 ET92050.8205
03:53 ET9510.79
03:55 ET5000.8205
03:57 ET2540.79
04:00 ET3690.82
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSQZ
SQZ Biotechnologies Co
24.4M
-0.3x
---
United StatesANGN
Angion Biomedica Corp
21.1M
-1.2x
---
United StatesCASI
CASI Pharmaceuticals Inc
28.3M
-1.0x
---
United StatesCDAK
Codiak BioSciences, Inc.
25.3M
-1.0x
---
United StatesHARP
Harpoon Therapeutics Inc
34.2M
-0.5x
---
United StatesNBRV
Nabriva Therapeutics PLC
4.7M
-0.1x
---
As of 2023-02-01

Company Information

SQZ Biotechnologies Company is a clinical-stage biotechnology company focused on unlocking the full potential of cell therapies to benefit patients with cancer, autoimmune and infectious diseases, and other serious conditions. In oncology, it is developing cell therapy platforms that are based on directing tumor antigen-specific immune activation via engineered antigen presentation. It has three oncology candidates in clinical trials across its SQZ Antigen Presenting Cell (APC), SQZ enhanced APC (eAPC) and SQZ Activating Antigen Carrier (AAC), cell therapy platforms. In its autoimmune diseases portfolio, the Company is developing its SQZ Tolerizing Antigen Carrier (TAC), cell therapy platform to restore immune tolerance to self-antigens or other autoimmune disease-associated antigens that are central to disease pathogenesis. APC platform is focused on generating CD8+ T cell responses. SQZAPCs are created by ex vivo engineering of a patient's own peripheral blood mononuclear cells.

Contact Information

Headquarters
200 Arsenal Yards Blvd, Suite 210WATERTOWN, MA, United States 02472
Phone
617-758-8672
Fax
302-655-5049

Executives

Chairman of the Board
Amy Schulman
Director
Howard Bernstein
Chief People Officer
David First
General Counsel
Lawrence Knopf
Chief Medical Officer
Marshelle Warren

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$24.4M
Revenue (TTM)
$21.9M
Shares Outstanding
29.5M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.73
Book Value
$4.41
P/E Ratio
-0.3x
Price/Sales (TTM)
1.1
Price/Cash Flow (TTM)
---
Operating Margin
-358.61%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.